Cargando…
1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model
Uveal melanoma (UM) is an intraocular cancer with propensity for liver metastases. The median overall survival (OS) for metastatic UM (MUM) is 1.07 years, with a reported range of 0.84–1.34. In primary UM, high cysteinyl leukotriene receptor 1 (CysLT(1)) expression associates with poor outcomes. Cys...
Autores principales: | Slater, Kayleigh, Bosch, Rosa, Smith, Kaelin Francis, Jahangir, Chowdhury Arif, Garcia-Mulero, Sandra, Rahman, Arman, O’Connell, Fiona, Piulats, Josep M., O’Neill, Valerie, Horgan, Noel, Coupland, Sarah E., O’Sullivan, Jacintha, Gallagher, William M., Villanueva, Alberto, Kennedy, Breandán N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868667/ https://www.ncbi.nlm.nih.gov/pubmed/36698840 http://dx.doi.org/10.3389/fmed.2022.1036322 |
Ejemplares similares
-
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells
por: Slater, Kayleigh, et al.
Publicado: (2020) -
Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors
por: Kennedy, Susan A., et al.
Publicado: (2020) -
1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours
por: Butler, Clare T., et al.
Publicado: (2019) -
Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
por: Murphy, Adrian G., et al.
Publicado: (2016) -
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor
por: Sundaramurthi, Husvinee, et al.
Publicado: (2022)